𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors

✍ Scribed by Taina A. Partanen; Kari Alitalo; Markku Miettinen

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
722 KB
Volume
86
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

The opinions and assertions contained herein are the expressed views of the authors and are not to be construed as official or reflecting the views of the Departments of the Army or Defense.

πŸ“œ SIMILAR VOLUMES

Lymphatic versus blood vascular endothel
Lymphatic versus blood vascular endothelial growth factors and receptors in humans
✍ Taina A. Partanen; Karri Paavonen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

## Abstract Three different growth factor systems have been described acting via endothelial cell‐specific receptor tyrosine kinases (RTKs). These are vascular endothelial growth factors (VEGFs), angiopoietins, and ephrins. Recent studies on gene targeting suggest that they play critical roles in e

Clinical significance of vascular endoth
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
✍ Mitsuyuki Arinaga; Tsuyoshi Noguchi; Shinsuke Takeno; Masao Chujo; Takashi Miura πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 491 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Vascular endothelial growth factor C (VEGF‐C) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFR‐3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the

Vascular endothelial growth factor C and
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck
✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 379 KB πŸ‘ 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph

Immunodetection and quantification of va
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues
✍ Hiroko Bando; Maren Brokelmann; Masakazu Toi; Kari Alitalo; Jonathan P. Sleeman; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 303 KB

## Abstract Vascular endothelial growth factor recpetor‐3 (VEGFR‐3) and its ligands, vascular endothelial growth factor‐C (VEGF‐C) and –D (VEGF‐D), are the major molecules involved in developmental and pathological lymphangiogenesis. Here we describe for the first time the development of a specific